尿液檢查市場規模、佔有率、成長分析、按測試、按應用、按最終用戶、按地區 - 行業預測，2025 年至 2032 年

預計2023年全球尿液檢查市場規模將達到24億美元，將從2024年的25.1億美元擴大到2032年的35.4億美元，預測期內（2025-2032年）的複合年成長率為4.4%。

受醫療設備（尤其是尿液分析儀和相關產品）進步的推動，尿液檢查市場預計將快速成長。醫療保健基礎設施的改善和日益成長的未滿足的健康需求，尤其是糖尿病等慢性病的盛行率不斷上升，正在推動對尿液檢查解決方案的需求。政府發起的篩檢項目，例如美國國立衛生研究院（NIH）在溫州進行的大規模尿液篩檢，有望提高疾病的早期發現率，並進一步刺激市場擴張。此外，男性和女性普遍存在的尿道感染發病率不斷上升，也增加了尿液檢查在診斷糖尿病和各種腎臟疾病方面發揮關鍵作用。整體而言，尿液檢查市場在新興市場將迎來顯著成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

尿液檢查市場規模：依檢測方式

• 市場概況
• 妊娠和不孕症檢測
• 尿液生化
• 尿沉渣檢查

尿液檢查市場規模（按應用）

• 市場概況
• 疾病篩檢
• 懷孕和生育

尿液檢查市場規模（依最終用戶分類）

• 市場概況
• 醫院和診所
• 診斷實驗室
• 居家照護環境
• 研究辦公室/實驗室

尿液檢查市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Cardinal Health（US）
• General Electric Company（US）
• Metropolis India（India）
• 77 Elektronika Kft（Hungary）
• Roche Diagnostics（Switzerland）
• Thermo Fisher Scientific（US）
• Sysmex Corporation（Japan）
• Abbott（US）
• Trinity Biotech（Ireland）
• ARKRAY Inc.（Japan）
• Dr Lal PathLabs（India）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Siemens（Germany）
• Sysmex Corporation（Japan）
• BioMaxima SA（Poland）

結論和建議

Global Urinalysis Test Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.51 billion in 2024 to USD 3.54 billion by 2032, growing at a CAGR of 4.4% during the forecast period (2025-2032).

The urinalysis test market is poised for rapid growth, driven by advancements in medical equipment, particularly in urine analyzers and related products. Improved healthcare infrastructure and rising unmet health needs, especially the increasing prevalence of chronic diseases like diabetes, are propelling demand for urine testing solutions. Screening programs initiated by governments, such as the significant urine screenings conducted by the National Institute of Health (NIH) in Wenzhou, are enhancing early disease detection and are expected to further stimulate market expansion. Additionally, the rising incidence of urinary tract infections, prevalent in both genders, is fueling the necessity for urinalysis testing, which plays a critical role in diagnosing diabetes and various renal issues. Overall, the market for urine tests is set for significant growth in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinalysis Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinalysis Test Market Segmental Analysis

Global Urinalysis Test Market is segmented by Application, End User, Test and region. Based on Test, the market is segmented into Pregnancy & Fertility Tests, Biochemical Urinalysis and Sediment Urinalysis. Based on Application, the market is segmented into Disease Screening and Pregnancy and Fertility. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care Setting and Research Laboratories & Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinalysis Test Market

The global urinalysis test market is primarily driven by the increasing prevalence of diabetes and urinary tract infections (UTIs), particularly in developing countries. The surge in UTI cases poses significant health risks, as untreated infections can lead to complications during childbirth and may spread to the kidneys, highlighting the critical need for timely diagnosis and treatment. As awareness of these conditions grows, the demand for urinalysis tests is expected to rise, further propelling market growth. Additionally, improved access to healthcare services and advancements in diagnostic technologies are enhancing the overall landscape of the urinalysis test market.

Restraints in the Global Urinalysis Test Market

One of the key restraints in the global urinalysis test market is the limited accessibility to advanced urine analyzers, particularly in developing countries where cost is a major concern. In these regions, healthcare providers often opt for more affordable devices that offer similar functionalities, leading to increased demand for budget-friendly alternatives. Furthermore, the lack of robust regulatory frameworks can result in an influx of substandard and refurbished products in the market, undermining the quality of diagnostic services and potentially risking patient safety. This scenario creates significant challenges for manufacturers aiming to introduce high-quality, innovative solutions in these emerging markets.

Market Trends of the Global Urinalysis Test Market

The Global Urinalysis Test market is experiencing a notable trend driven by advancements in diagnostic technology, particularly through automated urine analyzers and smartphone-integrated testing devices. These innovations enhance the precision and accessibility of urinalysis, catering to both healthcare professionals and patients. As chronic illnesses such as diabetes and kidney disease rise, the demand for efficient urinalysis tests is surging, reinforcing their integral role in early health problem detection and management. This expanding requirement for streamlined testing methods emphasizes urinalysis as a cornerstone of modern healthcare, propelling market growth and innovation in diagnostic approaches for better patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Urinalysis Test Market Size by Test & CAGR (2025-2032)

• Market Overview
• Pregnancy & Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

Global Urinalysis Test Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Screening
• Pregnancy and Fertility

Global Urinalysis Test Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care Setting
• Research Laboratories & Institute

Global Urinalysis Test Market Size & CAGR (2025-2032)

• North America (Application, End User, Test)
  • US
  • Canada
• Europe (Application, End User, Test)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End User, Test)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End User, Test)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End User, Test)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Cardinal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metropolis India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 77 Elektronika Kft (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr Lal PathLabs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMaxima SA (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations